MoffettNathanson cuts Chewy stock rating on weak organic growth

MoffettNathanson downgraded Chewy from Buy to Neutral and cut its price target to $22 from $50, citing limited upside and softer core growth. Chewy posted Q1 fiscal 2026 EPS of $0.43 versus $0.24 expected and revenue of $3.36 billion versus $3.35 billion expected, but it lowered full-year revenue guidance by about $200 million and guided Q2 below expectations. Growth is slowing to about 5.7% in fiscal 2026 at the midpoint, or 5.5% excluding Vet Clinics, versus 6.2% in fiscal 2025.

Analysis

The key signal is not the earnings beat; it is the margin of safety collapsing in the company’s narrative. When a consumer retailer has to cut growth while still spending to defend engagement, the market usually re-rates it from an “operator with leverage” to a “share-taker with cyclical exposure.” That transition tends to matter more over the next 2-3 quarters than any single quarter of EPS, because valuation multiples compress as investors discount lower terminal growth and weaker pricing power.

Second-order, this is a warning shot for discretionary pet spend, especially premium attachment and services adoption. If management is seeing pressure simultaneously in new customer quality and basket mix, the issue is likely broader than company-specific execution: it suggests the post-pandemic pet spending normalization is still working through the system and smaller competitors may be forced into promotion to defend share. That would support gross margin elsewhere in the category only if players have scale; otherwise it likely extends a deflationary cycle in consumables and accessories.

The contrarian setup is that near-term sentiment is already poor enough that another leg down may require evidence of a harder macro turn, not just softer guidance. The stock can stabilize if management can show that slower top-line growth is being offset by durable EBITDA margin expansion and lower customer acquisition spend, but that is a months-long proof point, not a days-long catalyst. The bigger risk is that the current debate centers on whether growth is merely slowing or structurally reverting to low single digits; if the latter, fair value can fall well below where analysts still have it anchored today.

Key Decisions for Investors

• Short CHWY into any relief rally over the next 1-3 weeks; use strength toward prior analyst-target reference levels as an entry, with a 6-10% downside window if the market re-prices to a lower growth multiple.
• Preferred expression: buy CHWY put spreads 1-2 months out to capture further guidance/estimate cuts while limiting theta; structure for ~2:1 to 3:1 payoff if the stock revisits the 52-week low and breaks it.
• Pair trade: short CHWY vs long a higher-quality discretionary winner with pricing power and visible growth (e.g., AMZN or COST) over 1-2 quarters, betting that the market rewards durable share gains over promotional defense.
• If already long, hedge with calls or reduce size ahead of the next guidance checkpoint; the risk is not another beat, but another reset in the implied terminal growth rate.